首页> 美国卫生研究院文献>Frontiers in Oncology >CO2 Transoral Microsurgery for Supraglottic Squamous Cell Carcinoma
【2h】

CO2 Transoral Microsurgery for Supraglottic Squamous Cell Carcinoma

机译:CO2经口显微手术治疗声门上鳞状细胞癌

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The present study analyzed the results of the endoscopic approach to T1, T2 and selected T3 supraglottic carcinoma with the aim of reviewing functional and oncologic outcomes after different types of endoscopic supraglottic laryngectomies. This is a retrospective clinical study of 42 consecutive patients (mean age of 61.8 years, 33 males, 9 females) treated by the senior author for supraglottic squamous cell carcinoma with a transoral CO2 laser approach and reviewed from November 2010 to September 2017. Surgical procedures were classified according to the European Laryngological Society. In addition to the standardized transoral supraglottic laryngectomies, we introduced a modified type IVb by sparing the inferior third of the arytenoid if not directly involved in the tumor. Swallowing was evaluated with the Swallowing Performance Status Scale reported by the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology. Survival probabilities were estimated using Kaplan-Meier curves. Two type I, 2 type IIa, 2 type IIb, 3 type IIIa, 12 type IIIb, 13 type IVa, 3 type modified IVb, and 5 type IVb supraglottic laryngectomies were performed. Twenty-one patients (50%) underwent primary neck dissection. The pathologic TNM classification according to the 8th edition of the American Joint Committee on Cancer system was as follows: 9 pT1cN0, 2 pT1N0, 1 pT1N1, 7 pT2cN0, 1 rypT2cN0, 9 pT2N0, 4 pT2N1, 2 ypT2N1, 2 pT3cN0, 2 rypT3cN0, 1 pT3N1, and 2 pT3N2b. Mean follow-up was 3.4 years (range of 9 months to 6 years). According to the Kaplan–Meier analysis, 5-year disease-specific survival, local-relapse-free survival, nodal-relapse-free survival, overall laryngeal preservation and overall survival of patients without previous head and neck radiotherapy/open surgery were 100%, 95.2%, 87.8%, 100%, and 64.6%, respectively. Patients who underwent type I, IIa, and IIb resections (n = 6) started oral feeding the day after surgery, patients who underwent type III-IVb modified resections (n = 31) started oral feeding 3–4 days after surgery, and patients who underwent standard type 4b resections (n = 5) started oral feeding 7 days after surgery. Three months after surgery, patients without a clinical history of previous head and neck radiotherapy/open surgery who underwent type III, IVa, and modified IVb resections showed significantly better swallowing compared to patients who underwent standard type IVb resection: grade 4–6 impairment of swallowing in 8 and 66.7% of cases, respectively (p = 0.006072); patients with a clinical history of previous head and neck radiotherapy/open surgery who underwent type III, IVa, and modified IVb resections showed not statistically significant better swallowing compared to patients who underwent standard type IVb resection: grade 4–6 impairment of swallowing at 3 months in 16.7% and 50% of cases, respectively (p = 0.23568). Transoral CO2 laser supraglottic laryngectomy is an oncologic sound alternative to traditional open neck surgery and chemo-radiotherapy. Recovery of swallowing is significantly worsened after total resection of the arytenoid. Modified type IVb procedure leaving intact, when possible, the inferior third of the arytenoid and consequently the glottic competence, improves functional outcome.
机译:本研究分析了内镜下治疗T1,T2和选定的T3声门上癌的结果,目的是回顾不同类型的内镜声门上喉切除术后的功能和肿瘤学结局。这是一项回顾性临床研究,回顾性研究了由资深作者经口CO2激光治疗的声门上鳞状细胞癌连续42例患者(平均年龄61.8岁,男33例,女9例),并于2010年11月至2017年9月进行了回顾性研究。根据欧洲喉科学会分类。除了标准化的经口声门上喉切除术外,我们还引入了改良的IVb型,如果不直接参与肿瘤,则保留下三分之一的关节突。用多国癌症支持治疗协会/国际口腔肿瘤学会报告的吞咽表现状态量表评估吞咽情况。使用Kaplan-Meier曲线估算生存率。进行了两种I型,2型IIa,2型IIb,3型IIIa,12型IIIb,13型IVa,3型改良IVb和5型IVb声门上喉切除术。 21例(50%)患者行原发性颈淋巴结清扫术。根据美国癌症联合委员会第八版的病理学TNM分类如下:9 pT1cN0、2 pT1N0、1 pT1N1、7 pT2cN0、1 rypT2cN0、9 pT2N0、4 pT2N1、2 ypT2N1、2 pT3N3、2 ,1 pT3N1和2 pT3N2b。平均随访时间为3.4年(范围为9个月至6年)。根据Kaplan–Meier分析,未进行过头颈部放疗/开放手术的患者的5年疾病特异性生存期,无局部复发生存期,无淋巴结复发生存期,喉总保存率和总生存期均为100% ,95.2%,87.8%,100%和64.6%。接受I,IIa和IIb型切除的患者(n = 6)在手术后第二天开始口服喂养,接受III-IVb型切除的患者(n = 31)在手术后3-4天开始口服喂养,接受标准4b型切除术(n = 5)的患者在术后7天开始口服喂养。手术后三个月,没有进行过头颈部放疗/开放手术的临床病史的患者,与接受标准IVb切除的患者相比,接受III,IVa和改良的IVb切除的患者吞咽明显好于:4-6级吞咽分别为8和66.7%(p = 0.006072);具有III,IVa型和改良IVb切除术且具有先前头颈部放疗/开放手术的临床病史的患者,与接受标准IVb切除术的患者相比,吞咽没有统计学上的显着改善:3级吞咽障碍为4–6级月分别占16.7%和50%的病例(p = 0.23568)。经口CO2激光声门上喉切除术是传统的开颈手术和化学放射疗法的肿瘤替代疗法。完全切除关节突后,吞咽的恢复明显恶化。改良的IVb型手术在可能的情况下保留完好无损的下半部的类人猿,从而改善声门功能,从而改善功能预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号